Frank Rimerman Advisors’s ResMed RMD Stock Holding History

Frank Rimerman Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Sell	1,274 -1,281	-50%	-$266K	0.01%	556
2026 Q1	$574K	Buy	2,555 +38	+2%	+$9.47K	0.04%	346
2025 Q4	$606K	Buy	2,517 +1,196	+91%	+$306K	0.04%	333
2025 Q3	$362K	Buy	1,321 +13	+1%	+$3.55K	0.02%	436
2025 Q2	$337K	Sell	1,308 -164	-11%	-$39.1K	0.02%	425
2025 Q1	$330K	Buy	1,472 +110	+8%	+$25.7K	0.03%	392
2024 Q4	$311K	Buy	1,362 +41	+3%	+$9.87K	0.02%	401
2024 Q3	$322K	Sell	1,321 -31	-2%	-$6.93K	0.02%	409
2024 Q2	$259K	Buy	+1,352	New	+$274K	0.02%	473

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Frank Rimerman Advisors's RMD Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its ResMed (RMD) stake by 50% in Q2 2026, selling an estimated $266K and leaving 1,274 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #556.

Frank Rimerman Advisors first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $606K in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Frank Rimerman Advisors held 1,274 shares of ResMed worth $248K as of Q2 2026.
Frank Rimerman Advisors sold 1,281 ResMed shares in Q2 2026, an estimated $266K.
ResMed made up 0.01% of Frank Rimerman Advisors's portfolio in Q2 2026, its #556 holding.
Frank Rimerman Advisors first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
Frank Rimerman Advisors's ResMed position peaked at $606K in Q4 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.